Alterations of Gut Microbiota in Pyogenic Liver Abscess Patients with and without Type 2 Diabetes Mellitus

被引:0
|
作者
Liu, Shanshan [1 ,2 ]
Ge, Xiaomeng [3 ]
Xu, Xizhan [4 ]
Zhang, Kang [1 ]
Lu, Xinxin [1 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Lab Med, 1 Dongjiaomin Lane, Beijing 100730, Peoples R China
[2] Xuzhou Med Univ, Affiliated Lianyungang Hosp, Peoples Hosp Lianyungang 1, Dept Infect Management, Lianyungang, Jiangsu, Peoples R China
[3] Chinese Acad Sci, Inst Microbiol, Microbial Resources & Big Data Ctr, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr, Beijing, Peoples R China
来源
关键词
Gut microbiota; Pyogenic liver abscess; type 2 diabetes mellitus; 16S rRNA sequencing; CLINICAL CHARACTERISTICS; EPIDEMIOLOGY; INFECTION; CHINA;
D O I
10.2147/IDR.S456423
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose: The clinical manifestations of pyogenic liver abscess (PLA) vary between patients with and without diabetes mellitus (DM). However, the relationship between PLA and the gut microbiome remains unknown. This study analyzed the composition of gut microbiota in PLA patients with and without DM and healthy controls (HCs) with the goal of identifying potential reasons for the observed variations in clinical manifestations. Patients and Methods: Using 16S ribosomal RNA(16S rRNA) gene sequencing, we analyzed the compositions of gut microbiota in 32 PLA patients with DM, 32 PLA patients without DM, and 29 matched HCs. Results: In PLA patients with DM, the D-dimer level, fibrinogen degradation products, and thrombin time were significantly higher compared to the PLA patients without DM ( P < 0.05). The abundance and diversity of intestinal flora were reduced in both groups of PLA patients compared with the HCs ( P < 0.05). Specifically, the PLA patients with DM showed significant decreases in the relative abundances of Bacteroides, Blautia, Prevotella9 , and Faecalibacterium , whereas Enterococcus and Escherichia-Shigella were relatively more abundant ( P < 0.05). Compared to PLA patients without DM, those with DM had lower relative abundances of Lactobacillus and Klebsiella ( P < 0.05) and showed different bacterial flora, including Anaerosporobacter and Megamonas . Conclusion: PLA patients with DM exhibited more severe clinical manifestations of PLA compared to patients without DM. It is important to monitor blood coagulation in PLA patients with DM to prevent the development of thrombotic diseases. Additionally, PLA patients with DM exhibit distinct differences in the composition and diversity of their intestinal flora compared to both PLA patients without DM and HCs.
引用
收藏
页码:2149 / 2158
页数:10
相关论文
共 50 条
  • [31] Correlation between alterations of gut microbiota and miR-122-5p expression in patients with type 2 diabetes mellitus
    Li, Lisha
    Li, Chaomin
    Lv, Meijun
    Hu, Qiongying
    Guo, Lixuan
    Xiong, Daqian
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (22)
  • [32] Alterations of the gut microbiota in type 2 diabetics with or without subclinical hypothyroidism
    Lv, Yanrong
    Liu, Rong
    Jia, Huaijie
    Sun, Xiaolan
    Gong, Yuhan
    Ma, Li
    Qiu, Wei
    Wang, Xiaoxia
    PEERJ, 2023, 11
  • [33] Altered Profiles of Gut Microbiota in Klebsiella pneumoniae-Induced Pyogenic Liver Abscess
    Chen, Nan
    Ling, Zong-Xin
    Jin, Tong-Tong
    Li, Ming
    Zhao, Sheng
    Zheng, Li-Shuang
    Xi, Xin
    Wang, Lin-Lin
    Chen, Ying-Ying
    Shen, Yue-Liang
    Zhang, Li-Ping
    Sun, Shao-cong
    CURRENT MICROBIOLOGY, 2018, 75 (07) : 952 - 959
  • [34] Altered Profiles of Gut Microbiota in Klebsiella pneumoniae-Induced Pyogenic Liver Abscess
    Nan Chen
    Zong-Xin Ling
    Tong-Tong Jin
    Ming Li
    Sheng Zhao
    Li-Shuang Zheng
    Xin Xi
    Lin-Lin Wang
    Ying-Ying Chen
    Yue-Liang Shen
    Li-Ping Zhang
    Shao-cong Sun
    Current Microbiology, 2018, 75 : 952 - 959
  • [35] Fusobacterium nucleatum Pyogenic Liver Abscess and the Role of Bacterial Virulence and Gut Microbiota Dysbiosis
    Louis-Jean, Scarlet F.
    Agrawal, Nirav
    Bisht, Sushrit
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [36] Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
    Wu, Jiaqiang
    Yang, Kangping
    Fan, Hancheng
    Wei, Meilin
    Xiong, Qin
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [37] Type-2 Diabetes Mellitus and the Gut Microbiota: Systematic Review
    Slouha, Ethan
    Rezazadah, Atbeen
    Farahbod, Kiana
    Gerts, Andrew
    Clunes, Lucy A.
    Kollias, Theofanis F.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [38] Effects of Smoking on the Gut Microbiota in Individuals with Type 2 Diabetes Mellitus
    Kondo, Yuriko
    Hashimoto, Yoshitaka
    Hamaguchi, Masahide
    Kaji, Ayumi
    Sakai, Ryosuke
    Inoue, Ryo
    Kashiwagi, Saori
    Mizushima, Katsura
    Uchiyama, Kazuhiko
    Takagi, Tomohisa
    Naito, Yuji
    Fukui, Michiaki
    NUTRIENTS, 2022, 14 (22)
  • [39] (-)-Epicatechin ameliorates type 2 diabetes mellitus by reshaping the gut microbiota and Gut-Liver axis in GK rats
    Zeng, Hongzhe
    Liu, Changwei
    Wan, Liwei
    Peng, Liyuan
    Wen, Shuai
    Fang, Wenwen
    Chen, Hongyu
    Wang, Kuofei
    Yang, Xiaomei
    Huang, Jianan
    Liu, Zhonghua
    FOOD CHEMISTRY, 2024, 447
  • [40] Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus
    Moreno-Indias, Isabel
    Cardona, Fernando
    Tinahones, Francisco J.
    Isabel Queipo-Ortuno, Maria
    FRONTIERS IN MICROBIOLOGY, 2014, 5